China's BrainCo Seeks Pre-IPO Funding at $1.3 Billion Valuation

BrainCo isn’t alone in China’s fledgling BCI race. Earlier this year, Shanghai-based StairMed Technology raised 350 million yuan ($48.7 million) in Series B financing and launched China’s first clinical trial for invasive brain-computer interfaces.

Credit: CFP

TMTPOST -- BrainCo, a Chinese brain-computer interface (BCI) startup aiming to rival Elon Musk’s Neuralink, is in talks to raise about $100 million in pre-IPO funding at a valuation exceeding $1.3 billion, as it prepares for a potential listing in Hong Kong or mainland China, according to people familiar with the matter.

Founded in 2015 by Harvard alumnus Han Bicheng, BrainCo—officially known as Zhejiang Qiangnao Technology Co.—has started early-stage preparations for a public offering, the people said, asking not to be identified discussing private information. The company has yet to finalize its listing venue or timeline, they added.

Based in Hangzhou, BrainCo is part of the so-called “Six Little Dragons”—a cohort of China’s most promising tech innovators that includes AI startup DeepSeek and e-commerce giant Alibaba Group Holding Ltd. The company specializes in bionic prosthetics and neural interface technology that enables humans to control computers with their minds.

BrainCo isn’t alone in China’s fledgling BCI race. Earlier this year, Shanghai-based StairMed Technology raised 350 million yuan ($48.7 million) in Series B financing and launched China’s first clinical trial for invasive brain-computer interfaces, local media outlet Yicai reported. BrainCo’s founder previously told the South China Morning Post he was considering an expansion into Hong Kong.

Talks around BrainCo’s financing and IPO remain fluid, and details could shift depending on market dynamics, the people said. Representatives for BrainCo did not respond to requests for comment.

The company’s funding efforts highlight growing investor appetite for next-generation tech startups in China, as the country’s venture capital ecosystem shows signs of revival after years of Covid-era stagnation and regulatory crackdowns. China’s top VC firms are now seeking to raise at least $2 billion in fresh funds, rekindling interest in sectors like AI, robotics, and advanced manufacturing.

Breakout successes like BrainCo, DeepSeek, and robotics firm Manus have galvanized a new wave of entrepreneurial activity, particularly in Hangzhou. The city’s “Six Little Dragons” also include game developer Game Science, known for the blockbuster title Black Myth: Wukong, as well as Deep Robotics, Unitree Robotics, and AI computing startup Manycore.

The resurgence of China’s early-stage tech scene underscores a broader reassessment by global investors, as signs of recovery emerge across the country’s startup ecosystem and macroeconomy.

本文系作者 zhangxinyue 授权钛媒体发表,并经钛媒体编辑,转载请注明出处、作者和本文链接
本内容来源于钛媒体钛度号,文章内容仅供参考、交流、学习,不构成投资建议。
想和千万钛媒体用户分享你的新奇观点和发现,点击这里投稿 。创业或融资寻求报道,点击这里

敬原创,有钛度,得赞赏

赞赏支持
发表评论
0 / 300

根据《网络安全法》实名制要求,请绑定手机号后发表评论

登录后输入评论内容

扫描下载App